评估型肝炎患者的长期结果

Muhammet Salih Tarhan1, Habip Gedik1, Kadriye Kart-Yasar1

  • 1Department of Infectious Diseases and Clinical Microbiology, the University of Health Sciences affiliated with Ministry of Health Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkiye.

概括

基化干扰素对型肝炎具有部分有效性,但不能消除肝硬化或肝癌的风险. 口服抗病毒药物在治疗这种肝病时没有额外的益处.